Ocean Biomedical, Inc. is a biopharmaceutical company focused on developing therapeutic products for oncology, fibrosis, infectious diseases, and inflammation. Their product candidates include monoclonal antibodies and small molecule drugs targeting various diseases like non-small cell lung cancer, glioblastoma multiforme, idiopathic pulmonary fibrosis, and COVID-19. The company was founded in 2019 and is located in Providence, Rhode Island.